O. Tatli Et Al. , "A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab," Heliyon , vol.9, no.11, 2023
Tatli, O. Et Al. 2023. A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab. Heliyon , vol.9, no.11 .
Tatli, O., Oz, Y., Dingiloglu, B., Yalcinkaya, D., Basturk, E., Korkmaz, M., ... Akbulut, L.(2023). A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab. Heliyon , vol.9, no.11.
Tatli, Ozge Et Al. "A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab," Heliyon , vol.9, no.11, 2023
Tatli, Ozge Et Al. "A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab." Heliyon , vol.9, no.11, 2023
Tatli, O. Et Al. (2023) . "A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab." Heliyon , vol.9, no.11.
@article{article, author={Ozge Tatli Et Al. }, title={A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab}, journal={Heliyon}, year=2023}